SEDAR Interim Financial Statements

[
  {
    "companyName": "Voyageur Pharmaceuticals Ltd.",
    "reportingPeriodEnd": "2026-02-28",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cashAndCashEquivalents": 75709,
      "deposits": 1550,
      "amountsReceivable": 167170,
      "inventory": 137436,
      "prepaidExpenses": 32371,
      "totalCurrentAssets": 414236,
      "reclamationDeposits": 14000,
      "equipmentNet": 2841,
      "explorationAndEvaluationAssets": 2517731,
      "totalAssets": 2948808,
      "accountsPayableAndAccruedLiabilities": 2204813,
      "cebaLoanCurrent": 40000,
      "researchGrant": 43257,
      "totalCurrentLiabilities": 2288070,
      "cebaLoanLongTerm": 0,
      "totalLiabilities": 2288070,
      "shareCapital": 12641553,
      "contributedSurplus": 3001281,
      "accumulatedOtherComprehensiveIncome": 12920,
      "deficit": -14995016,
      "totalShareholdersEquity": 660738,
      "totalLiabilitiesAndShareholdersEquity": 2948808
    },
    "incomeStatement": {
      "revenue": 19274,
      "costOfSales": 19274,
      "grossProfit": 0,
      "marketAndProductDevelopment": 283012,
      "shareBasedCompensation": 43750,
      "wagesDirectorAndCfoFees": 82745,
      "generalAndAdministrative": 28193,
      "investorRelationsTransferAgentFilingFees": 41328,
      "professionalFees": 80682,
      "consultingFees": 67430,
      "depreciation": 283,
      "totalExpenses": 627423,
      "netLoss": -627423,
      "foreignExchangeTranslationAdjustment": -8031,
      "comprehensiveLoss": -635454,
      "basicAndDilutedEarningsPerShare": 0,
      "weightedAverageSharesOutstanding": 178586978
    },
    "cashFlowStatement": {
      "netLoss": -627423,
      "depreciation": 283,
      "shareBasedCompensation": 43750,
      "unrealizedForeignExchangeIncomeLoss": -8031,
      "amountsReceivable": -31174,
      "inventory": -88264,
      "prepaidExpenses": 110327,
      "researchGrant": -53514,
      "accountsPayableAndAccruedLiabilities": 488918,
      "netCashUsedInOperatingActivities": -165128,
      "sharesIssuedOnPrivatePlacements": 0,
      "exerciseOfWarrants": 0,
      "exerciseOfBrokerWarrants": 0,
      "shareIssueCosts": 0,
      "netCashProvidedByFinancingActivities": 0,
      "explorationAndEvaluationExpenditures": -26217,
      "netCashUsedInInvestingActivities": -26217,
      "changeInCashAndCashEquivalents": -191345,
      "cashAndCashEquivalentsBeginning": 267054,
      "cashAndCashEquivalentsEnding": 75709
    },
    "derivedMetrics": {
      "cashPerShare": 0.0004,
      "workingCapitalPerShare": -0.0105
    },
    "investmentsAndOtherAssets": [
      {
        "type": "Mineral Property",
        "description": "Exploration and evaluation assets (Frances Creek, Jubilee Mountain, Paradox Basin)",
        "ownershipPercentage": null,
        "value": 2517731,
        "notes": "100% interest in Canadian properties and subject to joint venture dispute on Paradox Basin (Anson Resources)"
      },
      {
        "type": "Reclamation Deposit",
        "description": "Reclamation bonds posted with Province of British Columbia",
        "ownershipPercentage": null,
        "value": 14000,
        "notes": "Refundable upon completion of reclamation"
      }
    ],
    "shareStructure": {
      "authorizedShares": "Unlimited",
      "issuedShares": 178586978,
      "classesOfShares": ["Class A common shares"],
      "warrants": [
        {
          "number": 4668750,
          "exercisePrice": 0.15,
          "expiryDate": "2026-03-01"
        }
      ],
      "options": [
        {
          "number": 3400000,
          "exercisePrice": 0.07,
          "expiryDate": "2029-03-26"
        },
        {
          "number": 1050000,
          "exercisePrice": 0.10,
          "expiryDate": "2030-01-20"
        },
        {
          "number": 850000,
          "exercisePrice": 0.18,
          "expiryDate": "2031-04-01"
        },
        {
          "number": 100000,
          "exercisePrice": 0.09,
          "expiryDate": "2026-04-30"
        },
        {
          "number": 300000,
          "exercisePrice": 0.10,
          "expiryDate": "2032-09-19"
        },
        {
          "number": 2300000,
          "exercisePrice": 0.08,
          "expiryDate": "2033-04-03"
        },
        {
          "number": 300000,
          "exercisePrice": 0.07,
          "expiryDate": "2033-07-28"
        },
        {
          "number": 300000,
          "exercisePrice": 0.07,
          "expiryDate": "2034-03-26"
        },
        {
          "number": 600000,
          "exercisePrice": 0.06,
          "expiryDate": "2034-09-25"
        },
        {
          "number": 43000,
          "exercisePrice": 0.18,
          "expiryDate": "2030-06-18"
        },
        {
          "number": 306122,
          "exercisePrice": 0.25,
          "expiryDate": "2030-06-26"
        },
        {
          "number": 100000,
          "exercisePrice": 0.20,
          "expiryDate": "2035-07-10"
        },
        {
          "number": 500000,
          "exercisePrice": 0.26,
          "expiryDate": "2029-07-10"
        }
      ],
      "rightsAndConvertibleInstruments": "Deferred Share Units (DSU) plan: 378,651 DSUs granted as subsequent event (equity-settled)"
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "2026-02-28": {
          "wagesDirectorAndCfoFees": 139326,
          "shareBasedCompensation": 43750,
          "marketAndProductDevelopment": 0
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "Directors and officers (unspecified)",
          "description": "Accounts payable and accrued liabilities due to related parties",
          "amount": 958769,
          "period": "2026-02-28"
        },
        {
          "counterparty": "Tiger Ridge Resources Ltd. (related by common directors)",
          "description": "Vendor of mineral properties; royalty obligations",
          "amount": null,
          "period": "Ongoing"
        }
      ]
    },
    "subsequentEvents": [
      {
        "eventDate": "2026-03-01",
        "description": "Change of head office address",
        "impactValue": null
      },
      {
        "eventDate": "2026-03-01",
        "description": "Expiry of 4,668,750 share purchase warrants",
        "impactValue": null
      },
      {
        "eventDate": "2026-03-04",
        "description": "Grant of 378,651 DSUs to directors and former director",
        "impactValue": null
      },
      {
        "eventDate": "2026-03-04",
        "description": "Grant of 4,300,000 stock options to directors and officers at $0.1125, later repriced to $0.15",
        "impactValue": null
      },
      {
        "eventDate": "2026-03-04",
        "description": "Grant of 500,000 stock options to a contractor at $0.18",
        "impactValue": null
      },
      {
        "eventDate": "2026-03-24",
        "description": "Received second tranche of $140,000 from Alberta Innovates grant",
        "impactValue": 140000
      },
      {
        "eventDate": "2026-03-25",
        "description": "Announced non-brokered Life Offering for minimum $4,000,000 and maximum $7,500,000",
        "impactValue": null
      },
      {
        "eventDate": "2026-03-31",
        "description": "Received US$350,000 (CAD $487,465) first tranche of Bayer iodine project funding",
        "impactValue": 487465
      },
      {
        "eventDate": "2026-04-17",
        "description": "Shares for debt settlement: issued 888,888 units to settle $100,000 debt",
        "impactValue": 100000
      },
      {
        "eventDate": "2026-04-17",
        "description": "Stock option repricing: 4,300,000 options exercise price increased from $0.1125 to $0.15 (subject to TSXV approval)",
        "impactValue": null
      }
    ]
  }
]